Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cariogenic bacteria metabolism refers to the biochemical processes by which oral bacteria metabolize dietary carbohydrates, leading to acid production that demineralizes tooth enamel and dentin. The primary metabolic pathway is glycolysis, resulting in the production of lactic, acetic, and formic acids. Key species include Streptococcus mutans and Scardovia wiggsiae, which exhibit aciduricity and efficient carbohydrate utilization. Targeting these metabolic pathways is a potential strategy for preventing dental caries.
Inhibition of bacterial enzymes involved in carbohydrate metabolism; disruption of biofilm formation; alteration of oral pH; interference with bacterial transport systems.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cariogenic Bacteria Metabolism.